Evommune (EVMN) Non-cash Items (2024 - 2026)

Evommune (EVMN) has 3 years of Non-cash Items data on file, last reported at $92.0 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $92.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $92.0 million (changed N/A YoY), and the FY2025 annual result was $54.5 million, up 9216.75% from the prior year.
• Non-cash Items rose to $92.0 million in Q1 2026 per EVMN's latest filing, from $54.5 million in the prior quarter.
• Over five years, Non-cash Items peaked at $92.0 million in Q1 2026 and troughed at $585000.0 in Q4 2024.
• A 3-year average of $38.5 million and a median of $30.7 million in 2025 frame the typical range for Non-cash Items.
• On a YoY basis, Non-cash Items climbed as much as 9216.75% in 2025 and fell as far as 9216.75% in 2025.
• A 3-year view of Non-cash Items shows it stood at $585000.0 in 2024, then jumped by 9216.75% to $54.5 million in 2025, then surged by 68.75% to $92.0 million in 2026.
• Business Quant data shows EVMN's Non-cash Items at $92.0 million in Q1 2026, $54.5 million in Q4 2025, and $6.9 million in Q3 2025.